로딩 중…
지수 로딩 중…
Rhythm Pharmaceuticals, Inc.
RYTM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$96.60+0.80%
2026-06-18
Price Chart
Rhythm Pharmaceuticals, Inc.+57.12%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $6.62B |
| Revenue | $217M |
| Net Income | $-203M |
| Total Assets | $442M |
| Net Assets | $123M |
| Value | |
| P/B | 53.86x |
| P/S | 30.48x |
| FCF Yield | -1.82% |
| Profitability | |
| ROE | -164.91% |
| ROA | -45.82% |
| Op. Margin | -90.89% |
| Revenue Growth | 83.81% |
| Financial Health | |
| Debt Ratio | 259.88% |
| Total Debt | $227M |
| FCF | $-120M |
| Cash | $62M |
| Current Ratio | 4.17x |
| Performance | |
| 1Y Return | 57.12% |
| 1M Return | 10.77% |
| From 52W High | -20.95% |
| 1Y MDD | -35.54% |
| Trading | |
| Volume | 1,463,992 shares |
| Trading Value | $143M |
| Per Share | |
| EPS | $-2.94 |
| BPS | $2.08 |